The prevalence of awake bruxism is about 20% among the adult population and that of sleep bruxism is 8% of the population. Temporomandibular disorders (TMD) characterise a number of disorders often painful with different causes resulting in dysfunction of joint and/or muscles of mastication. Myofascial pain is estimated that about 25% of the entire population have internal derangement and is usually treated with non-surgical methods. Osteonecrosis of the jaw (ONJ) is characterised by exposure and necrosis of areas of the jaw. The true incidence of ONJ in patients on bisphosphonates (BP) is not known. This review discusses the mechanisms and management of some of the related oral disorders such as bruxism, temporomandibular dysfunction, myofascial pain and osteonecrosis of the jaw.
KeywordsAwake bruxism Sleep bruxism Temporomandibular disorders Myofascial pain Osteonecrosis of the jaw
- 2.Cogen JD, Kelly JJ Jr, Loghmanee DA. Sleep bruxism. Pathogenesis and pathophysiology. http://www.medmerits.com/index.php/article/sleep_bruxism/PS accessed 26 May 2016.
- 4.Ku BD, Seo SW, Kim E-J, Park KC, Suh M-K, Na DL. P3-024: Diurnal bruxism in advanced Alzheimer’s disease. Alz Dement 2008;4(4Suppl T523. https://doi.org/10.1016/j.jalz.2008.05.1587.
- 8.Nekora-Azale A, Evlioglu G, Ordulu M, Issever H. Prevalence of symptoms associated with temporo-mandibular disorders in a Turkish population. J Oral Rehabil. 2006;33(2):61–4.Google Scholar
- 11.University of Washington, Diagnostic Radiology Anatomy Module, 2001. Uwmsk.org/tmj/anatomy.html accessed 7 August 2016.
- 13.Mehta NR. Internal temporo-mandibular joint derangement. Merck Manuals Professional version. http://www.merckmanuals.com/professional/dental-disorders/temporomandibular-disorders/internal-temporomandibular-joint-derangement. Accessed 7 August 2016.
- 15.Costa ALF, D’Abreu AD., Cendes F. Temporomandibular joint internal derangement: Association with headache, joint effusion, bruxism and joint pain. Revista Romana de Stomatologie. 2008;LIV (3):193–197.Google Scholar
- 16.Barkin S, Weinberg S. Internal derangement of temporomandibular joint: The role arthroscopic surgery and arthrocentesis. J Can Dent Assoc. 2000;66:199–203.Google Scholar
- 19.Finley JE. Physical medicine and rehabilitation for myofascial pain. http://emedicine.medscape.com/article/313007-overview accessed 7 August 2016.
- 21.Hoff A, Toth B, Altundag K, Guaneri V, Nooka A, Desronleaux K, et al. Osteonecrosis of the jaw in patients requiring intravenous bisphosphonate therapy. J Clin Oncol. 2006;20: S55.Google Scholar
- 22.Dimopoulos MA, Kastritis E, Anagnostopoulos A, et al. Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid. Hematologica. 2006;91:968–71.Google Scholar
- 23.Kahn A. Bisphosphonates associated osteonecrosis of the jaw. Can Fam Physician. 2008;54(7):1019–1021.Google Scholar
- 24.Huang YF, Chang CT, Muo CH, Tsai CH, Shen YF, Wu CZ. Impact of bisphosphonates –related osteoporosis of the jaw in osteoporotic patients after dental extraction: A population based cohort study. PLOS. One 2015;10(4):e0120756. https://doi.org/10.1371/journal.pone.0120756.
- 26.Okabe R, Inaba M, Nakatsuka K, Miki T, Naka K, Moriguchi A, et al. Significance of serum CrossLaps as a predictor of changes in bone mineral density during oestrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type 1 collagen and urinary deoxypyridoline. J Bone Miner Metab. 2004;22(2):127–31.CrossRefPubMedGoogle Scholar
- 27.Goss A. The CTX test and bisphosphonate-associated ONJ. ADA Dental Therapuetics Committee, 2008.Google Scholar
- 28.Marx RE. Oral and intravenous bisphosphonate-induced osteonecrosis of the jaws. History, etiology, prevention and treatment. Quintessence Pub Co. 2006Google Scholar
- 29.Rodrigues CA, Magri LV, Melchior M de O, Mazetto MO. Evaluation of the impact on quality of life of patients with temporomandibular disorders. Rev dor. 2015;16(3): https://doi.org/10.5935/1806-0013.20150036.